Brief: Adial Pharmaceuticals Announces Pricing Of $0.75 Million At-The-Market Registered Direct Offering
Feb 24 (Reuters) - Adial Pharmaceuticals Inc ADIL.O :
* ADIAL PHARMACEUTICALS ANNOUNCES PRICING OF $0.75 MILLION
AT-THE-MARKET REGISTERED DIRECT OFFERING
Source text for Eikon: ID:nGNX5Y5TTh
Further company coverage: ADIL.O
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)